Concurrent inhibition of NF‐κB, cyclooxygenase‐2, and epidermal growth factor receptor leads to greater anti‐tumor activity in pancreatic cancer

Shadan Ali, Sanjeev Banerjee, Jacqueline M. Schaffert, Bassel F. El‐Rayes, Philip A. Philip, Fazlul H. Sarkar

Open source

DOI
10.1002/jcb.22523
Published
2010-03-08
Container
Journal of Cellular Biochemistry
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcb.22523,
  title = {Concurrent inhibition of NF‐κB, cyclooxygenase‐2, and epidermal growth factor receptor leads to greater anti‐tumor activity in pancreatic cancer},
  author = {Shadan Ali and Sanjeev Banerjee and Jacqueline M. Schaffert and Bassel F. El‐Rayes and Philip A. Philip and Fazlul H. Sarkar},
  year = {2010},
  journal = {Journal of Cellular Biochemistry},
  doi = {10.1002/jcb.22523},
  url = {https://doi.org/10.1002/jcb.22523}
}

RIS

TY  - JOUR
TI  - Concurrent inhibition of NF‐κB, cyclooxygenase‐2, and epidermal growth factor receptor leads to greater anti‐tumor activity in pancreatic cancer
AU  - Shadan Ali
AU  - Sanjeev Banerjee
AU  - Jacqueline M. Schaffert
AU  - Bassel F. El‐Rayes
AU  - Philip A. Philip
AU  - Fazlul H. Sarkar
PY  - 2010
JO  - Journal of Cellular Biochemistry
DO  - 10.1002/jcb.22523
UR  - https://doi.org/10.1002/jcb.22523
ER  - 

APA

Ali, S., Banerjee, S., Schaffert, J. M., El‐Rayes, B. F., Philip, P. A., & Sarkar, F. H. (2010). Concurrent inhibition of NF‐κB, cyclooxygenase‐2, and epidermal growth factor receptor leads to greater anti‐tumor activity in pancreatic cancer. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.22523

Source records